-
DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy
03 Feb 2026 15:44 GMT
… directed DXd antibody drug conjugate (ADC … of chemotherapy (paclitaxel, nab-paclitaxel, capecitabine, … medicine camizestrant.
PARP inhibitor olaparib is a targeted treatment … RESEARCH FDA CLINICAL TRIALS BIOTECHNOLOGY GENERAL HEALTH PHARMACEUTICAL HEALTH …
-
<![CDATA[Dr Shubham Pant Highlights Progress and Promise in Pancreatic Cancer Treatment]]>
03 Feb 2026 14:21 GMT
… predominant approach by current treatment standards, recent advances in … the Department of Gastrointestinal Medical Oncology at The … gemcitabine and nab-paclitaxel. This was a global trial. But now … there, and those clinical trials have been reported. …
-
Datroway granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy
03 Feb 2026 14:29 GMT
… Drug Administration (FDA) grants Priority Review to applications for medicines … robust and durable treatment responses, including an … with previous clinical trials of Datroway in … choice of chemotherapy (paclitaxel, nab-paclitaxel, capecitabine, carboplatin or …
-
A Bubble-Driven Drug Delivery System Enhances Oral Absorption and Antipyretic Efficacy of Poorly Water-Soluble Andrographolide
03 Feb 2026 08:52 GMT
… of lipophilic curcumin and paclitaxel.10,11 The system … PEG4000) were provided by Tasly Pharmaceutical Group Co., Ltd (Tianjin … -Ringer (KR) solution (Pricella Biotechnology Co., Ltd., Wuhan, China). … for kidney-targeted drug delivery in the treatment of renal …
-
DATROWAY® Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy
03 Feb 2026 08:14 GMT
… Drug Administration (FDA) grants Priority Review to applications for medicines … Medical Oncology (#ESMO25) Congress. In the trial … trials of DATROWAY in breast cancer. Grade 3 or higher treatment … of chemotherapy (paclitaxel, nab-paclitaxel, capecitabine, …
-
Paclitaxel Expands TREM2+ Macrophages, Reducing Efficacy
03 Feb 2026 05:04 GMT
… and researchers to ponder how drug formulations shape immune cell dynamics … of cancer immunotherapy and precision medicine, this study pioneers a path … in response to paclitaxel versus nab-paclitaxel treatment
Article Title: Paclitaxel drives TREM2⁺ macrophage …
-
Recent Advances in Mitochondria-Targeted Nano-Drug Delivery Systems for Cancer Therapy
02 Feb 2026 07:56 GMT
… and major challenge in medical research. According to … for precision cancer treatment.
Mitochondrial Structural Characteristics … and paclitaxel to conquer drug resistance. Front Bioeng Biotechnol. 2021 … targeting and imaging. Pharmaceutics. 2022;15(1):103 …
-
The Prospects of Palmitylethanolamide in Tumor Prevention and Treatment
30 Jan 2026 23:54 GMT
… Precision Therapy and Translational Medicine
Molecular precision therapy … cancer patients treated with paclitaxel and colorectal cancer … inflammatory approach to sarcopenia. Pharmaceutics. 2022;14(3):648. … . Davis P. Novel drug treatments for pain in advanced …
-
Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma
30 Jan 2026 15:59 GMT
… S. Food and Drug Administration (FDA) accepted the … Cancer treatment strategy and European Society for Medical Oncology … and in combination with paclitaxel), adenoid cystic carcinoma … license-holder, Jiangsu Hengrui Pharmaceuticals Company Ltd., (Hengrui …
-
Incyte Announces Positive CHMP Opinion for Zynyz® for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal
30 Jan 2026 18:16 GMT
… carboplatin and paclitaxel as a first-line treatment 4 Incyte … Multiple Malignancies) clinical trial program for retifanlimab includes … for patients with unmet medical needs. Through the … )
5 Clinical Trials.Gov. Carboplatin-paclitaxel with retifanlimab or …
About
© 1995-2026